ROKAPAX vs. Genki

Our diverse selection of products includes VNA, PACS systems, Radiology Information Systems (RIS), Diagnostic Viewers, and AI-enhanced Medical Diagnostic Support Solutions (MDSS) specifically designed for modalities such as MMG, CT chest imaging, ECG, and X-ray endoprosthesis imaging. With a robust user base of over 300,000 active individuals each month and 20,000 diagnostic devices flawlessly integrated with our PACS|VNA, we take pride in offering state-of-the-art technological solutions that aim to improve patient care significantly. We are keen to impart our knowledge in the field of healthcare digitalization, which is focused on elevating patient experiences through optimized diagnostic workflows. Our dedication extends to promoting the seamless adoption of our solutions to enhance the efficiency of professionals such as radiologists, oncologists, and cardiologists in their daily tasks. Leveraging 14 years of collaboration with 5,000 clinics, we have honed our essential skills to create a comprehensive and flexible platform that addresses the entire imaging workflow, free from vendor limitations. Furthermore, our AI-powered medical decision support systems are crafted to effectively prioritize cases with identified pathologies on a single interface, employing a red-yellow-green alert system to bolster clinical decision-making. This groundbreaking method guarantees that healthcare practitioners can concentrate on what is most important: providing outstanding care to their patients, thereby fostering a healthcare environment that is more responsive and patient-centered. Ultimately, our innovations not only streamline processes but also facilitate better health outcomes for all involved.

Genki is an innovative AI-based solution that leverages X-Ray and CT scans for public health screenings, specifically targeting the detection of chest diseases such as Tuberculosis and COVID-19. By combining artificial intelligence with expert oversight, this system enhances imaging workflows, facilitating faster report generation and boosting productivity for imaging specialists. Employing state-of-the-art technology, Genki improves the analysis of infectious diseases like TB and COVID-19, providing swift prescreening and triage capabilities essential for timely healthcare responses. The workflow has been carefully optimized to ensure a smooth process for imaging assessment, diagnosis, and reporting, while an intelligent notification system helps mitigate the pressures typically associated with reporting tasks. Among its many features, Genki excels at classifying, localizing, and quantifying lesions with precision. Additionally, this solution prioritizes point-of-care diagnostics, which play a critical role in bridging gaps in disease elimination efforts, and is compatible with mobile X-ray units and CT scanners for immediate triage and prescreening applications. The integration of Genki into healthcare systems not only streamlines processes but also significantly enhances overall public health outcomes, ultimately aiding in the fight against infectious diseases. By leveraging advanced technology, Genki marks a significant advancement in the realm of medical imaging and public health strategies.